6 results on '"Wertheim, Kenneth Y."'
Search Results
2. PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers
- Author
-
Martí-Bonmatí, Luis, Alberich-Bayarri, Ángel, Ladenstein, Ruth, Blanquer, Ignacio, Segrelles, J. Damian, Cerdá-Alberich, Leonor, Gkontra, Polyxeni, Hero, Barbara, García-Aznar, J. M., Keim, Daniel, Jentner, Wolfgang, Seymour, Karine, Jiménez-Pastor, Ana, González-Valverde, Ismael, Martínez de las Heras, Blanca, Essiaf, Samira, Walker, Dawn, Rochette, Michel, Bubak, Marian, Mestres, Jordi, Viceconti, Marco, Martí-Besa, Gracia, Cañete, Adela, Richmond, Paul, Wertheim, Kenneth Y., Gubala, Tomasz, Kasztelnik, Marek, Meizner, Jan, Nowakowski, Piotr, Gilpérez, Salvador, Suárez, Amelia, Aznar, Mario, Restante, Giuliana, and Neri, Emanuele
- Published
- 2020
- Full Text
- View/download PDF
3. A Mathematical Model of Lymphangiogenesis in a Zebrafish Embryo
- Author
-
Wertheim, Kenneth Y. and Roose, Tiina
- Published
- 2017
- Full Text
- View/download PDF
4. Mathematical Model of Clonal Evolution Proposes a Personalised Multi-Modal Therapy for High-Risk Neuroblastoma.
- Author
-
Italia, Matteo, Wertheim, Kenneth Y., Taschner-Mandl, Sabine, Walker, Dawn, and Dercole, Fabio
- Subjects
- *
TUMOR treatment , *THERAPEUTIC use of antineoplastic agents , *MEDICINE , *GENETICS , *NEUROBLASTOMA , *GENETIC mutation , *SEQUENCE analysis , *MATHEMATICAL models , *ACCURACY , *DRUG resistance , *CANCER patients , *RISK assessment , *SURVIVAL rate , *MEDICAL protocols , *THEORY , *CYCLOPHOSPHAMIDE , *GENOTYPES , *RARE diseases , *ALGORITHMS , *VINCRISTINE , *PHYSIOLOGY ,BODY fluid examination - Abstract
Simple Summary: Neuroblastoma is a rare type of cancer that usually affects children. The high-risk patients' expected survival rate is less than 50%. One reason is the lack of precision in the standard treatment protocol: a one-size-fits-all multi-modal therapy. The study presented in this paper was designed to address this deficit by optimising the use of two chemotherapeutic agents—vincristine and cyclophosphamide—during induction chemotherapy—the part of the protocol that shrinks the primary tumour before surgical removal. We combined a mathematical model and an optimisation algorithm to identify the best chemotherapy schedules for a cohort of virtual patients with different initial tumour compositions. Our results reveal novel strategies to exploit a pair of drugs with different levels of efficacy, provide a platform on which to individualise induction chemotherapy, and lay the foundation for a personalised therapy that leverages targeted therapies, multi-region sequencing, liquid biopsies, and modern computational methods to improve today's multi-modal therapy. Neuroblastoma is the most common extra-cranial solid tumour in children. Despite multi-modal therapy, over half of the high-risk patients will succumb. One contributing factor is the one-size-fits-all nature of multi-modal therapy. For example, during the first step (induction chemotherapy), the standard regimen (rapid COJEC) administers fixed doses of chemotherapeutic agents in eight two-week cycles. Perhaps because of differences in resistance, this standard regimen results in highly heterogeneous outcomes in different tumours. In this study, we formulated a mathematical model comprising ordinary differential equations. The equations describe the clonal evolution within a neuroblastoma tumour being treated with vincristine and cyclophosphamide, which are used in the rapid COJEC regimen, including genetically conferred and phenotypic drug resistance. The equations also describe the agents' pharmacokinetics. We devised an optimisation algorithm to find the best chemotherapy schedules for tumours with different pre-treatment clonal compositions. The optimised chemotherapy schedules exploit the cytotoxic difference between the two drugs and intra-tumoural clonal competition to shrink the tumours as much as possible during induction chemotherapy and before surgical removal. They indicate that induction chemotherapy can be improved by finding and using personalised schedules. More broadly, we propose that the overall multi-modal therapy can be enhanced by employing targeted therapies against the mutations and oncogenic pathways enriched and activated by the chemotherapeutic agents. To translate the proposed personalised multi-modal therapy into clinical use, patient-specific model calibration and treatment optimisation are necessary. This entails a decision support system informed by emerging medical technologies such as multi-region sequencing and liquid biopsies. The results and tools presented in this paper could be the foundation of this decision support system. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. A multi-approach and multi-scale platform to model CD4+ T cells responding to infections.
- Author
-
Wertheim, Kenneth Y., Puniy, Bhanwar Lal, La Fleur, Alyssa, Shah, Ab Rauf, Barberis, Matteo, and Helikar, Tomáš
- Subjects
- *
T cells , *MULTISCALE modeling , *PHENOMENOLOGICAL biology , *ORDINARY differential equations , *METABOLIC regulation , *MICROARRAY technology , *DNA microarrays , *INFLUENZA - Abstract
Immune responses rely on a complex adaptive system in which the body and infections interact at multiple scales and in different compartments. We developed a modular model of CD4+ T cells, which uses four modeling approaches to integrate processes at three spatial scales in different tissues. In each cell, signal transduction and gene regulation are described by a logical model, metabolism by constraint-based models. Cell population dynamics are described by an agent-based model and systemic cytokine concentrations by ordinary differential equations. A Monte Carlo simulation algorithm allows information to flow efficiently between the four modules by separating the time scales. Such modularity improves computational performance and versatility and facilitates data integration. We validated our technology by reproducing known experimental results, including differentiation patterns of CD4+ T cells triggered by different combinations of cytokines, metabolic regulation by IL2 in these cells, and their response to influenza infection. In doing so, we added multi-scale insights to single-scale studies and demonstrated its predictive power by discovering switch-like and oscillatory behaviors of CD4+ T cells that arise from nonlinear dynamics interwoven across three scales. We identified the inflamed lymph node's ability to retain naive CD4+ T cells as a key mechanism in generating these emergent behaviors. We envision our model and the generic framework encompassing it to serve as a tool for understanding cellular and molecular immunological problems through the lens of systems immunology. Author summary: CD4+ T cells are a key part of the adaptive immune system. They differentiate into different phenotypes to carry out different functions. They do so by secreting molecules called cytokines to regulate other immune cells. Multi-scale modeling can potentially explain their emergent behaviors by integrating biological phenomena occurring at different spatial (intracellular, cellular, and systemic), temporal, and organizational scales (signal transduction, gene regulation, metabolism, cellular behaviors, and cytokine transport). We built a computational platform by combining disparate modeling frameworks (compartmental ordinary differential equations, agent-based modeling, Boolean network modeling, and constraint-based modeling). We validated the platform's ability to predict CD4+ T cells' emergent behaviors by reproducing their differentiation patterns, metabolic regulation, and population dynamics in response to influenza infection. We then used it to predict and explain novel switch-like and oscillatory behaviors for CD4+ T cells. On the basis of these results, we believe that our multi-approach and multi-scale platform will be a valuable addition to the systems immunology toolkit. In addition to its immediate relevance to CD4+ T cells, it also has the potential to become the foundation of a virtual immune system. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. A theoretical analysis of the scale separation in a model to predict solid tumour growth.
- Author
-
de Melo Quintela, Bárbara, Hervas-Raluy, Silvia, Garcia-Aznar, Jose Manuel, Walker, Dawn, Wertheim, Kenneth Y., and Viceconti, Marco
- Subjects
- *
MODELS & modelmaking , *MULTISCALE modeling , *SOLID mechanics , *TUMOR microenvironment , *TUMORS , *EAR ossicles - Abstract
• New approach to the scale separation for the orchestration of mathematical models. • Each model represents the phenomenon within a specified portion of space–time. • This is based on the resolution of the experimental methods and computational cost. • Scale separation of a patient specific personalised cancer treatment model as example. Solid tumour growth depends on a host of factors which affect the cell life cycle and extracellular matrix vascularization that leads to a favourable environment. The whole solid tumour can either grow or wither in response to the action of the immune system and therapeutics. A personalised mathematical model of such behaviour must consider both the intra- and inter-cellular dynamics and the mechanics of the solid tumour and its microenvironment. However, such wide range of spatial and temporal scales can hardly be modelled in a single model, and require the so-called multiscale models, defined as orchestrations of single-scale component models, connected by relation models that transform the data for one scale to another. While multiscale models are becoming common, there is a well-established engineering approach to the definition of the scale separation, e.g., how the spatiotemporal continuum is split in the various component models. In most studies scale separation is defined as natural, linked to anatomical concepts such as organ, tissue, or cell; but these do not provide reliable definition of scales: for examples skeletal organs can be as large as 500 mm (femur), or as small as 3 mm (stapes). Here we apply a recently proposed scale-separation approach based on the actual experimental and computational limitations to a patient-specific model of the growth of neuroblastoma. The resulting multiscale model can be properly informed with the available experimental data and solved in a reasonable timeframe with the available computational resources. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.